It is well-established that DNase I degrades NETs-DNA and is therefore therapeutically promising in conditions where NETs contribute to their pathophysiology (sepsis, myocardial infarction, and ischemic stroke (12, 14, 15). Here, DNASE1 is linked to ischemic stroke.